• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Manufacturing
    • Markets
    • Top 10
    • Buyers' Guide
    • Events
    • Microsites
    • More
  • Magazine
  • News
  • Exclusives
  • Manufacturing
  • Markets
  • Top 10
  • Buyers' Guide
  • Events
  • Microsites
  • Current & Past Issues
    Features
    Departments
    Columns
    Editorial
    Digital Edition
    Subscribe Now
    Advertise Now
    Editorial Guidelines
    eNewsletter Archive
    Top Features
    Instrumentation Innovations: A Review of Instrument Manufacturing

    The Total Package: Packaging and Sterilization for Orthopedics

    Helping Nature Take Its Course: A Biologics Breakdown

    Making the Grade: Orthopedic Materials Spotlight

    Mending Mishaps: A Trauma Technology Overview
    Breaking News
    Certifications
    Clinical Trials
    Device Approvals & Patents
    Financial & Deals
    International
    Market Data & Trends
    OEM News
    Orthopedic Innovators
    People
    Product & Service Releases
    Products
    Quality, Recalls & Risk
    Regulatory & Legal
    Supplier & Contract Mfg.
    Live From Shows
    Top News & Features
    Colfax Decides to Divide Its Businesses

    Stryker Corp.'s 2020 Sales Slip 3.6 Percent

    Bioventus Appoints Managing Director, China and Asia Pacific

    Full-Year Sales Down 12 Percent at Zimmer Biomet

    Lincotek Medical Expands Coatings and Additive Capacity
    3-D Printing/Additive Mfg.
    Assembly & Automation
    Biocompatibility & Testing
    Clean Room
    Coatings/Surface Modification
    Contract Manufacturing
    Design
    Extrusion
    Finishing
    Forging & Casting
    Instruments, Cases & Trays
    International/Offshoring
    Laser Processing
    Materials
    Machining & Tooling
    Molding
    Packaging & Sterilization
    Prototyping
    Research & Developement
    Software & Quality
    Staffing, Training & Prof. Dev.
    Supply Chain

    Medtech Matters: FDA’s Ambiguity on Hyaluronic Acid

    Orthopedic Innovators: Optimizing the Contract Services Experience

    Fusion Robotics Receives FDA Clearance for Spinal Navigation and Robotics System

    First Implantation of CTL Amedica's Minimally Invasive Flex Tower

    NuVasive Nabs Simplify Medical for $150M
    Biologics
    Bracing/Prosthetics
    Extremities
    Imaging
    Instruments
    Large Joint
    MIS/Robotics
    Spine/Neurology
    Trauma/Sports
    Top Markets
    Orthopedic Solutions from Man’s Best Friend

    The FDA’s Flip-Flop on Hyaluronic Acid

    HSS, Zimmer Biomet's Solution for the Episode of Orthopedic Care

    Rising to the Challenge: Q&A with AAOS Second VP Dr. Savoie

    Teleconferencing in the OR
    Companies
    Categories
    Company Capabilities
    White Papers
    Add New Company
    International Buyers Guide Companies
    ARCH Medical Solutions

    NN Life Sciences/Paragon Medical

    Master Bond Inc.

    Sayan Orthopaedics Ltd.

    Tecomet
    Industry Events
    Webinars
    • Magazine
      • Current & Past Issues
      • Features
      • Editorial
      • Departments
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • Companies
      • Categories
      • Company Capabilities
      • White Papers
      • Add Your Company
    • Manufacturing
      • 3-D Printing/Additive Mfg.
      • Assembly & Automation
      • Biocompatibility & Testing
      • Clean Room
      • Coatings/Surface Modification
      • Contract Manufacturing
      • Design
      • Extrusion
      • Finishing
      • Forging & Casting
      • Instruments, Cases & Trays
      • International/Offshoring
      • Laser Processing
      • Materials
      • Machining & Tooling
      • Molding
      • Packaging & Sterilization
      • Prototyping
      • Research & Developement
      • Software & Quality
      • Staffing, Training & Prof. Dev.
      • Supply Chain
    • Markets
      • Biologics
      • Bracing/Prosthetics
      • Extremities
      • Imaging
      • Instruments
      • Large Joint
      • MIS/Robotics
      • Spine/Neurology
      • Trauma/Sports
    • Top 10
    • Online Exclusives
    • Slideshows
    • Videos
    • Webinars
    • Events
      • Industry Events
    • Live from Show Event
    • About Us
      • About Us
      • Contact Us
      • Privacy Policy
      • Terms of Use
      • Advertise With Us
    Columns

    A Spectrum of Value and Its Importance in Orthopedic Trauma

    Three orthopedic surgeons speak with the founder of The Orthopaedic Implant Company on value-based healthcare.

    A Spectrum of Value and Its Importance in Orthopedic Trauma
    The Orthopaedic Implant Company’s external fixation system is a perfect example of maximizing value, saving ORs an average of $3,000 per procedure.
    Related CONTENT
    • Colfax Decides to Divide Its Businesses
    • Full-Year Sales Down 12 Percent at Zimmer Biomet
    • Lincotek Medical Expands Coatings and Additive Capacity
    • SeaSpine Releases Reef TO (TLIF Oblique) Interbody System
    • Orthopedic Innovators: Optimizing the Contract Services Experience
    Peter Althausen, M.D., Orthopedic Surgeon; Co-Founder, The Orthopaedic Implant Company08.11.20
    Before the pandemic turned the world more than a little topsy-turvy, the phrase value-based care hovered over nearly every healthcare conversation in some fashion. It was often only an ideal though, nothing more than a target for hospitals and health systems to spend their time aiming at rather than ever actually pulling the trigger on. However, many of those same hospitals and health systems now find themselves in situations where value-based care must become their new reality if they are to continue helping the thousands of patients who need them.

    Nowhere is this need for value seen more clearly and felt more sharply than in orthopedic trauma, where convention in delivering care currently continues to reign supreme. Whether it’s in the academic arena, a community setting, or a rural practice, value can play a vital role in improving healthcare across a spectrum of environments, so I wanted to gather the thoughts of a few orthopedic surgeons in a variety of settings to learn about what they’re doing to truly deliver on this idea of value-based care.

    I welcomed Dr. Brian Cunningham, an orthopedic trauma surgeon in Bloomington, Minn.; Dr. Ryan Eggers, an orthopedic trauma surgeon in St. George, Utah; and Dr. Owen Kelly, an orthopedic surgery specialist in Russellville, Ark., to provide their expert perspectives and insights.

    Dr. Peter Althausen: Why is it important to create value in orthopedic trauma?

    Dr. Brian Cunningham:
    Orthopedic trauma is equal opportunity. Emergent injuries can happen to anyone—a CEO or a janitor, a student or a retired professor. We need to provide the best possible care to all patients. It is critical with limited resources that we focus on creating value-based care. This is not an option but a requirement. We are stewards of the trauma care system and in order to be there for our patients, we need to maximize patient outcomes while reducing the cost. Value mandates both parts—outcome and cost—are measured and managed.

    Dr. Ryan Eggers: Value is commonly described as a relationship between cost and outcome. As an orthopedic trauma surgeon, a good patient outcome is my highest priority. However, because I depend on a functional system in a resource-limited environment, my ability to treat one patient is, to a small degree, dependent on how I treat all of the others. So if I can achieve the same—or even better—patient outcomes while decreasing cost, I have added value to the system that will ultimately increase my ability to serve all patients.

    Dr. Owen Kelly: I serve a largely rural and blue-collar community. My patients work hard to provide for their families, but as healthcare costs continue to steadily rise, it makes it harder for them to do that. In any situation, if you are improving value for your patients, you are helping them in ways that go beyond simply healing the injury.

    Dr. Althausen: Value-based care is one of healthcare’s most often-discussed talking points. What kind of positive benefits has it brought in your experiences? What are some of the components that still need improvement?

    Dr. Cunningham:
    Value-based care has transformed the way our community thinks about delivering orthopedic care. For the first time we are actually measuring how our patients are doing from their perspective with patient-reported outcomes while we simultaneously track the cost of care. We have taken a very qualitative process—recovery—and made it quantifiable. This has been rolled into cost which has historically been a black box, but new techniques, such as Time-Driven Activity-Based Costing,1 has created transparency around the cost to actually deliver care. These advances have set the table to measure and optimize the value of healthcare, and the field of orthopedics has become a leader in this arena.

    Two very tangible benefits of value-driven care are, first, widespread adoption of patient reported outcome [PRO] data collection and analytics. Value cannot be measured without PROs and they have become the lynch pin for optimizing care. Second, the increased pressure on implant companies to increase competition and transparency around cost. This industry has existed on 500 percent plus margins for decades with little resistance. Value-driven care isn’t just for the physician; it must be collaborative with industry as well.

    Dr. Eggers: In many offices I have worked in, the operating profit margin is thin. Thus, the ability to continue serving an ever-increasing number of patients is dependent on efficient utilization of scarce resources. I have seen small and medium practices grow and expand by focusing on value-based care. I have also seen many patients with limited ability to pay for their medical bills benefit from value-focused care delivery by giving them the same outcome with a lower cost.

    I have seen a large amount of material and time inefficiency in orthopedic trauma—as well as healthcare in general—when the consequences of that waste are disconnected from the individuals making the decisions. The ubiquitous discussion and illustrated application of value-based care brings that concept to the forefront in the minds of decision-makers at all levels of the system, increasing the chance they will recognize an opportunity to save costs, improve outcomes, or both. Improvement in providing value-based care will come with an investment by all stakeholders. Even more improvement will come when the specifics of what entails value-based delivery are commonly known and become habitual.

    Dr. Kelly: Value-based care has broadened my perspective on the duration and pathway of care that I choose for my patients. Treating people now means treating them in a way that accounts for potential clinical and/or economic pitfalls that could arise later. If we treat for long-term outcomes, there’s a lot of value in that. Reimbursement is the biggest component needing improvement to strengthen value-based care. There are a lot of strategies and initiatives hospitals use to drive down the cost of supplies, but in the end, it’s the doctor and the hospital, together, that must decide on when and how to maximize value.

    Dr. Althausen: How has the pandemic impacted your ability to provide value and care for your patients? What long-lasting changes do you foresee in a post-pandemic orthopedic trauma environment?

    Dr. Cunningham:
    The pandemic has had little effect on the orthopedic trauma landscape. We rotated weeks initially when the scope locally was unknown; however, it has basically resumed with business as usual. The primary change that may be long lasting is an increased footprint for telemedicine. It’s unclear if patients will accept this new route as concerns over the virus decrease, but certainly there has been a dramatic uptick in utilization over the last three months.

    Dr. Eggers: The suspension of elective and non-emergent surgeries has had a large negative impact on the operations in the OR. With decreased revenue from fewer procedures, some staff were furloughed or laid off. The resulting loss of institutional knowledge made modifying materials and workflows to save time and money much more difficult. There was also a shift in focus from optimizing value-based care to learning, creating, and enforcing COVID-19 related protocols, so advances in care pathways were temporarily slowed.

    Dr. Kelly: The pandemic, and the subsequent distancing we needed to implement to combat it, had us all re-thinking every aspect of our practices. Virtual health, telemedicine—the use of technology to meet with patients has been catalyzed by the pandemic and will be widely accepted going forward.

    Dr. Althausen: What are some of the key elements that currently help you reduce the cost of care for your patients?

    Dr. Cunningham:
    I could talk about this for hours. Here are a couple big principles: First, you have to pursue information and know how much your implants cost. This is, and always will be, the key driver of cost. It is the area where a surgeon has the most control and influence to make value-driven decisions. The second is with site of care delivery. More and more orthopedic surgery is being done in the ASC or outpatient setting—tibial nail, non-unions, etc.—and these can all be done safely outside the hospital setting. Finally, the other areas—such as durable medical equipment, physical therapy, and dressings—are all areas to influence cost.

    Dr. Eggers: First and foremost in my experience: implants. Implants are one of the most consistent high-cost elements of orthopedic trauma surgery, which is why using high-value implants is one of the single best ways to decrease cost of care without compromising safety or outcomes. Other intra-operative measures include careful setup of preference cards, working with OR managers and sterile processing departments to optimize trays and packs, and limiting the number of disposable items used and opened. Surgeons should spend time learning the relative costs of different items and instruments so they can make an educated decision on whether or not a certain piece of equipment is necessary.

    Dr. Kelly: At many points throughout the continuum of care for a patient, I question what is necessary to arrive at an optimal outcome. Are there unnecessary elements inflating prices that I can do away with? Those will be the first things to go. I want the best value in implants when an indication calls for implantables. Patients are completely overwhelmed when confronted with orthopedic surgery. My job is to provide stewardship for them. If they don’t ask about high-value implants, it doesn’t mean I shouldn’t use them. If implants have been clinically proven to provide the same equivalent outcomes attained by premium-branded ones, and they’re going to save my patient, my facility, and me a lot of money, then I’m using them, and that’s generally why I avoid using the branded implants altogether. There’s a better way to do it. 

    Reference
    1. bit.ly/odt200721


    Dr. Peter Althausen has been practicing at the Reno Orthopaedic Clinic since 2005, and co-founded The Orthopaedic Implant Company, dedicated to value and transparency, in 2010. He is subspecialty trained in trauma and focuses on both pediatric and adult fracture care. He currently serves as a clinical assistant professor at the University of Nevada School of Medicine, where he teaches and mentors both medical and college students. Dr. Althausen presents annually at multiple national meetings and routinely teaches the latest techniques in fracture care to physicians, nurses, and other medical personnel. He has published a variety of scientific articles and textbook chapters concerning many aspects of orthopedic trauma care, including ethical practices and approaches to value-based care. Dr. Althausen is board certified by the American Board of Orthopaedic Surgery. 
    Suggested For You
    Colfax Decides to Divide Its Businesses Colfax Decides to Divide Its Businesses
    Full-Year Sales Down 12 Percent at Zimmer Biomet Full-Year Sales Down 12 Percent at Zimmer Biomet
    Lincotek Medical Expands Coatings and Additive Capacity Lincotek Medical Expands Coatings and Additive Capacity
    SeaSpine Releases Reef TO (TLIF Oblique) Interbody System SeaSpine Releases Reef TO (TLIF Oblique) Interbody System
    Orthopedic Innovators: Optimizing the Contract Services Experience Orthopedic Innovators: Optimizing the Contract Services Experience
    First Implantation of CTL Amedica First Implantation of CTL Amedica's Minimally Invasive Flex Tower
    Nexus Spine Implants for Use in Spinal Surgeries Become Available Nexus Spine Implants for Use in Spinal Surgeries Become Available
    Nexus Spine Announces Availability of Spine Surgery Implants Nexus Spine Announces Availability of Spine Surgery Implants
    Washington University Professor Honored for Functional Cartilage Engineering Research Washington University Professor Honored for Functional Cartilage Engineering Research
    Ranfac, Endocellutions Form Cervos Medical Ranfac, Endocellutions Form Cervos Medical
    FDA OKs Additive Ortho FDA OKs Additive Ortho's Patient-Specific Talus Spacer
    Sports Injury Doctor Recognized for Research on Epidemiology, Severe Athletic Injuries Sports Injury Doctor Recognized for Research on Epidemiology, Severe Athletic Injuries
    C2Dx Buys Stryker C2Dx Buys Stryker's T/Pump
    FDA OKs Acuitive Technologies FDA OKs Acuitive Technologies' CITREFIX Knotless Suture Anchor
    Acquisitions Set to Propel Global Orthopedics Market to $64 Billion by 2025 Acquisitions Set to Propel Global Orthopedics Market to $64 Billion by 2025

    Related Columns

    • Striving to Attain a Gain on the Pain

      Striving to Attain a Gain on the Pain

      A growing number of orthopedic patients are wrestling with fear, perhaps fueled in part by variant virus strains believed to be more contagious.
      Michael Barbella, Managing Editor 02.08.21

    • Rethink Your Orthopedic ASC Strategy, Part 1

      Rethink Your Orthopedic ASC Strategy, Part 1

      ASCs have adopted a strategy to focus on predictable, low-risk procedures with lower complication rates in an out-of-hospital setting.
      Maria Shepherd, President and Founder, Medi-Vantage 02.08.21

    • Pandemic-Level Playing Field: How COVID-19 Made Space for Progress

      Pandemic-Level Playing Field: How COVID-19 Made Space for Progress

      Pandemic restrictions may have diminished certain advantages large companies hold over small and mid-sized competitors.
      Dawn A. Lissy, Founder & President, Empirical 02.08.21


    • Tips for Reigniting Your MDR/IVDR Preparation

      Tips for Reigniting Your MDR/IVDR Preparation

      To get the MDR/IVDR preparation ball rolling again, here are four processes to help refocus on achieving compliance with the updated regulations.
      Nicolle Cannon, Founder and CEO, Cannon Quality Group LLC 02.08.21

    • Biologics
      An FDA Regulatory Perspective on Bone Grafts

      An FDA Regulatory Perspective on Bone Grafts

      There are various bone grafts with different composition, source, mechanical strength, and functional biological mechanisms.
      Mehdi Kazemzadeh-Narbat, Ph.D., Senior Associate, Regulatory Affairs, MCRA LLC 02.08.21

    • Packaging & Sterilization
      Building a More Transparent Healthcare Supply Chain with UDI

      Building a More Transparent Healthcare Supply Chain with UDI

      The FDA’s 2013 Unique Device Identification (UDI) Rule sets specific requirements for medical device labeling to improve traceability and patient safety.
      Beth Wells, Senior Director, Community Engagement, Healthcare, GS1 US 02.08.21


    • Stryker Strikes Back After Pandemic Slump

      Stryker Strikes Back After Pandemic Slump

      Late last year, Stryker announced it would snap up Wright Medical to fortify its position in the trauma and extremities markets.
      Sam Brusco, Associate Editor 11.18.20

    • Large Joint
      Obesity and the Impact on Hip and Knee Implants

      Obesity and the Impact on Hip and Knee Implants

      Obesity causes multiple health issues, and the COVID-19 pandemic is only adding to the problem.
      Maria Shepherd, President and Founder, Medi-Vantage 11.18.20

    • Virtually the Same? The Challenges of Online Conferences

      Virtually the Same? The Challenges of Online Conferences

      Like everyone else on the planet, I’m turning increasingly to virtual solutions to our physical challenges in the midst of a pandemic.
      Dawn A. Lissy, Founder & President, Empirical 11.18.20


    • 13 Mistakes to Avoid in a 510k Submission

      13 Mistakes to Avoid in a 510k Submission

      The FDA 510(k) review process can broadly be divided into two steps—acceptance review and substantive review.
      Samradni Patil, Regulatory Consultant and Writer, Kolabtree 11.18.20

    • Contract Manufacturing
      A Supply Chain Strategy for Pandemic Survival

      A Supply Chain Strategy for Pandemic Survival

      Medical device supply chain managers will likely conclude that 2020 is a year best forgotten.
      Tony Freeman, President, A.S. Freeman Advisors LLC 11.18.20

    • Medical Device Equivalence Requirements Strengthened under the EU MDR

      Medical Device Equivalence Requirements Strengthened under the EU MDR

      This column focuses on the directive under EU 2017/745 on medical devices (MDR), highlighting some of the changes in claiming and demonstrating equivalence.
      Cindy Boyer, Senior Manager, International Regulatory Affairs, MCRA LLC 11.18.20


    • Solid Footing During Shaky Times: Current Compliance Considerations

      Solid Footing During Shaky Times: Current Compliance Considerations

      The changes and challenges wrought by COVID-19 have significantly impacted the medtech industry.
      Bryan Brosseau, Founder and Principal Consultant, Brosseau Consulting LLC 11.18.20

    • A Wrinkle in the COVID-19 Financial Recovery

      A Wrinkle in the COVID-19 Financial Recovery

      A British Journal of Surgery study projected the global pandemic would postpone or outright cancel 6.3 million orthopedic procedures.
      Michael Barbella, Managing Editor 09.15.20

    • Research & Development
      Trends for Orthopedic Contract R&D and Manufacturing

      Trends for Orthopedic Contract R&D and Manufacturing

      Over the past 10 years, medtech manufacturers from startups to giants have grown their levels of outsourcing to contract R&D and manufacturing partners.
      Maria Shepherd, President and Founder, Medi-Vantage 09.15.20


    Trending
    • Mini MRI For Hand And Wrist Imaging Can Be Used Nearly Anywhere
    • FDA Breakthrough Device Designation Given To Active Implants For NUsurface Meniscus Implant
    • Mini MRI for Hand and Wrist Imaging Can Be Used Nearly Anywhere
    • The Evolution Of Knee Brace Technology
    • ARCH Global Precision Acquires LISI Medical Jeropa Inc.
    Breaking News
    • Colfax Decides to Divide Its Businesses
    • Stryker Corp.'s 2020 Sales Slip 3.6 Percent
    • Bioventus Appoints Managing Director, China and Asia Pacific
    • Full-Year Sales Down 12 Percent at Zimmer Biomet
    • Lincotek Medical Expands Coatings and Additive Capacity
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

    • Instrumentation Innovations: A Review of Instrument Manufacturing
    • The Total Package: Packaging and Sterilization for Orthopedics
    • Helping Nature Take Its Course: A Biologics Breakdown
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Thymoquinone Inhibits Viral Infection in In Vitro Settings, New Study Finds
    IFT Transitions 2021 Annual Event to Digital Experience
    NY Federal Judge Enters Permanent Injunction Against Dietary Supplement Manufacturer
    Coatings World

    Latest Breaking News From Coatings World

    Sherwin-Williams Announces Resignation of President and COO
    Ashland Completes Expansion and Relocation of Viatel Bioresorbable Polymers Manufacturing Facility
    Evonik Receives Sustainability Award from EcVadis
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Cretex CFO Announces Retirement
    New AI-Based Tool Developed for Coronary Artery Analysis, Intervention Planning
    First Reported Use of Pulse Biosciences' CellFX System
    Contract Pharma

    Latest Breaking News From Contract Pharma

    AGC Biologics Expands Cell and Gene Facility in Italy
    Celonic to Boost Cell & Gene Therapy Production
    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Ulta Beauty Opens in Herald Square
    Elizabeth Arden Taps Sui He as Global Brand Ambassador
    Natura &Co Outperforms the Global Market in Q4 2020
    Happi

    Latest Breaking News From Happi

    What You're Reading on Happi.com
    Indie Beauty Innovators Wanted
    Cosmetic Chemists Seek Mentors
    Ink World

    Latest Breaking News From Ink World

    Massilly North America Adds Koenig & Bauer MetalStar 3 Metal Decorating Press
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Access Direct Mail Doubles Revenue with SCREEN's Truepress Jet520HD
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Arjobex America welcomes Maggie Naberezny to sales team
    Henkel publishes 30th Sustainability Report
    Avery Dennison Smartrac launches new Circus Pro inlays
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    FPInnovations Develops Biodegradable Mask
    Sani Professional Sanitizing and Disinfecting Products Approved by EPA
    Autefa Solutions Offers Fully Automated Line for Protective Mask Production
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Colfax Decides to Divide Its Businesses
    Stryker Corp.'s 2020 Sales Slip 3.6 Percent
    Bioventus Appoints Managing Director, China and Asia Pacific
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login